Barroso-Sousa, Romualdo
Ott, Patrick A.
Article History
First Online: 15 November 2018
Compliance with Ethical Standards
:
: Romualdo Barroso-Sousa declares that he has no conflict of interest.Patrick A. Ott has received research funding from Bristol-Myers Squibb, Genentech, Merck, AstraZeneca/MedImmune, CytomX Therapeutics, Celldex, and Armo Biosciences; and has received compensation from Bristol-Myers Squibb, Merck, Genentech, Celldex, CytomX Therapeutics, Pfizer, Alexion, Amgen, and Novartis for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.